Biomarkers are considered appropriate tools for the early detection, therapeutic monitoring and prognostic evaluation of various diseases. In particular, the use of protein microarrays has become established as a powerful tool for large scale biological assay testing.
Of particular interest is the use of protein microarrays for immune response profiling, through which a disease-specific antibody repertoire may be defined. The antigens and antibodies discovered by this work are useful for developing clinical tests that can be used for diagnosis, prognosis, disease severity and the right choice of therapy. The discovery of novel biomarkers for specific diseases should enable personalized medicine. INTER-ARRAY® is specialized in the development of protein arrays.